The global market for Ocular Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ocular Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Delivery Devices.

The Ocular Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ocular Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ocular Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ocular Drug Delivery Devices Market Report

Report Metric	Details
Report Name	Ocular Drug Delivery Devices Market
CAGR	5%
Segment by Type	Ocular Implant Microneedle Ocular Inserts Punctal Plugs Viscosurgical Devices Others
Segment by Application	Hospitals Eye Clinics Homecare Setting Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Alcon Vision, Carl Zeiss, Glaukos Corporation, Ocular Therapeutix, Graybug Vision, Santen Pharmaceutical, Clearside Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ocular Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ocular Drug Delivery Devices Market report?

Ans: The main players in the Ocular Drug Delivery Devices Market are Alcon Vision, Carl Zeiss, Glaukos Corporation, Ocular Therapeutix, Graybug Vision, Santen Pharmaceutical, Clearside Biomedical

What are the Application segmentation covered in the Ocular Drug Delivery Devices Market report?

Ans: The Applications covered in the Ocular Drug Delivery Devices Market report are Hospitals, Eye Clinics, Homecare Setting, Others

What are the Type segmentation covered in the Ocular Drug Delivery Devices Market report?

Ans: The Types covered in the Ocular Drug Delivery Devices Market report are Ocular Implant, Microneedle, Ocular Inserts, Punctal Plugs, Viscosurgical Devices, Others

1 Ocular Drug Delivery Devices Market Overview

1.1 Product Definition

1.2 Ocular Drug Delivery Devices by Type

1.2.1 Global Ocular Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031)

1.2.2 Ocular Implant

1.2.3 Microneedle

1.2.4 Ocular Inserts

1.2.5 Punctal Plugs

1.2.6 Viscosurgical Devices

1.2.7 Others

1.3 Ocular Drug Delivery Devices by Application

1.3.1 Global Ocular Drug Delivery Devices Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Eye Clinics

1.3.4 Homecare Setting

1.3.5 Others

1.4 Global Ocular Drug Delivery Devices Market Size Estimates and Forecasts

1.4.1 Global Ocular Drug Delivery Devices Revenue 2020-2031

1.4.2 Global Ocular Drug Delivery Devices Sales 2020-2031

1.4.3 Global Ocular Drug Delivery Devices Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Ocular Drug Delivery Devices Market Competition by Manufacturers

2.1 Global Ocular Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)

2.2 Global Ocular Drug Delivery Devices Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Ocular Drug Delivery Devices Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Ocular Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ocular Drug Delivery Devices, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ocular Drug Delivery Devices, Product Type & Application

2.7 Global Key Manufacturers of Ocular Drug Delivery Devices, Date of Enter into This Industry

2.8 Global Ocular Drug Delivery Devices Market Competitive Situation and Trends

2.8.1 Global Ocular Drug Delivery Devices Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Ocular Drug Delivery Devices Players Market Share by Revenue

2.8.3 Global Ocular Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Ocular Drug Delivery Devices Market Scenario by Region

3.1 Global Ocular Drug Delivery Devices Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Ocular Drug Delivery Devices Sales by Region: 2020-2031

3.2.1 Global Ocular Drug Delivery Devices Sales by Region: 2020-2025

3.2.2 Global Ocular Drug Delivery Devices Sales by Region: 2026-2031

3.3 Global Ocular Drug Delivery Devices Revenue by Region: 2020-2031

3.3.1 Global Ocular Drug Delivery Devices Revenue by Region: 2020-2025

3.3.2 Global Ocular Drug Delivery Devices Revenue by Region: 2026-2031

3.4 North America Ocular Drug Delivery Devices Market Facts & Figures by Country

3.4.1 North America Ocular Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Ocular Drug Delivery Devices Sales by Country (2020-2031)

3.4.3 North America Ocular Drug Delivery Devices Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Ocular Drug Delivery Devices Market Facts & Figures by Country

3.5.1 Europe Ocular Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Ocular Drug Delivery Devices Sales by Country (2020-2031)

3.5.3 Europe Ocular Drug Delivery Devices Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ocular Drug Delivery Devices Market Facts & Figures by Region

3.6.1 Asia Pacific Ocular Drug Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Ocular Drug Delivery Devices Sales by Region (2020-2031)

3.6.3 Asia Pacific Ocular Drug Delivery Devices Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Ocular Drug Delivery Devices Market Facts & Figures by Country

3.7.1 Latin America Ocular Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Ocular Drug Delivery Devices Sales by Country (2020-2031)

3.7.3 Latin America Ocular Drug Delivery Devices Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ocular Drug Delivery Devices Market Facts & Figures by Country

3.8.1 Middle East and Africa Ocular Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Ocular Drug Delivery Devices Sales by Country (2020-2031)

3.8.3 Middle East and Africa Ocular Drug Delivery Devices Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Ocular Drug Delivery Devices Sales by Type (2020-2031)

4.1.1 Global Ocular Drug Delivery Devices Sales by Type (2020-2025)

4.1.2 Global Ocular Drug Delivery Devices Sales by Type (2026-2031)

4.1.3 Global Ocular Drug Delivery Devices Sales Market Share by Type (2020-2031)

4.2 Global Ocular Drug Delivery Devices Revenue by Type (2020-2031)

4.2.1 Global Ocular Drug Delivery Devices Revenue by Type (2020-2025)

4.2.2 Global Ocular Drug Delivery Devices Revenue by Type (2026-2031)

4.2.3 Global Ocular Drug Delivery Devices Revenue Market Share by Type (2020-2031)

4.3 Global Ocular Drug Delivery Devices Price by Type (2020-2031)

5 Segment by Application

5.1 Global Ocular Drug Delivery Devices Sales by Application (2020-2031)

5.1.1 Global Ocular Drug Delivery Devices Sales by Application (2020-2025)

5.1.2 Global Ocular Drug Delivery Devices Sales by Application (2026-2031)

5.1.3 Global Ocular Drug Delivery Devices Sales Market Share by Application (2020-2031)

5.2 Global Ocular Drug Delivery Devices Revenue by Application (2020-2031)

5.2.1 Global Ocular Drug Delivery Devices Revenue by Application (2020-2025)

5.2.2 Global Ocular Drug Delivery Devices Revenue by Application (2026-2031)

5.2.3 Global Ocular Drug Delivery Devices Revenue Market Share by Application (2020-2031)

5.3 Global Ocular Drug Delivery Devices Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Alcon Vision

6.1.1 Alcon Vision Company Information

6.1.2 Alcon Vision Description and Business Overview

6.1.3 Alcon Vision Ocular Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Alcon Vision Ocular Drug Delivery Devices Product Portfolio

6.1.5 Alcon Vision Recent Developments/Updates

6.2 Carl Zeiss

6.2.1 Carl Zeiss Company Information

6.2.2 Carl Zeiss Description and Business Overview

6.2.3 Carl Zeiss Ocular Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Carl Zeiss Ocular Drug Delivery Devices Product Portfolio

6.2.5 Carl Zeiss Recent Developments/Updates

6.3 Glaukos Corporation

6.3.1 Glaukos Corporation Company Information

6.3.2 Glaukos Corporation Description and Business Overview

6.3.3 Glaukos Corporation Ocular Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Glaukos Corporation Ocular Drug Delivery Devices Product Portfolio

6.3.5 Glaukos Corporation Recent Developments/Updates

6.4 Ocular Therapeutix

6.4.1 Ocular Therapeutix Company Information

6.4.2 Ocular Therapeutix Description and Business Overview

6.4.3 Ocular Therapeutix Ocular Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Ocular Therapeutix Ocular Drug Delivery Devices Product Portfolio

6.4.5 Ocular Therapeutix Recent Developments/Updates

6.5 Graybug Vision

6.5.1 Graybug Vision Company Information

6.5.2 Graybug Vision Description and Business Overview

6.5.3 Graybug Vision Ocular Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Graybug Vision Ocular Drug Delivery Devices Product Portfolio

6.5.5 Graybug Vision Recent Developments/Updates

6.6 Santen Pharmaceutical

6.6.1 Santen Pharmaceutical Company Information

6.6.2 Santen Pharmaceutical Description and Business Overview

6.6.3 Santen Pharmaceutical Ocular Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Santen Pharmaceutical Ocular Drug Delivery Devices Product Portfolio

6.6.5 Santen Pharmaceutical Recent Developments/Updates

6.7 Clearside Biomedical

6.7.1 Clearside Biomedical Company Information

6.7.2 Clearside Biomedical Description and Business Overview

6.7.3 Clearside Biomedical Ocular Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Clearside Biomedical Ocular Drug Delivery Devices Product Portfolio

6.7.5 Clearside Biomedical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ocular Drug Delivery Devices Industry Chain Analysis

7.2 Ocular Drug Delivery Devices Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ocular Drug Delivery Devices Production Mode & Process Analysis

7.4 Ocular Drug Delivery Devices Sales and Marketing

7.4.1 Ocular Drug Delivery Devices Sales Channels

7.4.2 Ocular Drug Delivery Devices Distributors

7.5 Ocular Drug Delivery Devices Customer Analysis

8 Ocular Drug Delivery Devices Market Dynamics

8.1 Ocular Drug Delivery Devices Industry Trends

8.2 Ocular Drug Delivery Devices Market Drivers

8.3 Ocular Drug Delivery Devices Market Challenges

8.4 Ocular Drug Delivery Devices Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Santen Pharmaceutical

Clearside Biomedical

Alcon Vision

List of Tables

Table 1. Global Ocular Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Ocular Drug Delivery Devices Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Ocular Drug Delivery Devices Market Competitive Situation by Manufacturers in 2024

Table 4. Global Ocular Drug Delivery Devices Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Ocular Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Ocular Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Ocular Drug Delivery Devices Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Ocular Drug Delivery Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Ocular Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Ocular Drug Delivery Devices, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Ocular Drug Delivery Devices, Product Type & Application

Table 12. Global Key Manufacturers of Ocular Drug Delivery Devices, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Ocular Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Drug Delivery Devices as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Ocular Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Ocular Drug Delivery Devices Sales by Region (2020-2025) & (K Units)

Table 18. Global Ocular Drug Delivery Devices Sales Market Share by Region (2020-2025)

Table 19. Global Ocular Drug Delivery Devices Sales by Region (2026-2031) & (K Units)

Table 20. Global Ocular Drug Delivery Devices Sales Market Share by Region (2026-2031)

Table 21. Global Ocular Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Ocular Drug Delivery Devices Revenue Market Share by Region (2020-2025)

Table 23. Global Ocular Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Ocular Drug Delivery Devices Revenue Market Share by Region (2026-2031)

Table 25. North America Ocular Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Ocular Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 27. North America Ocular Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 28. North America Ocular Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Ocular Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Ocular Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Ocular Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 32. Europe Ocular Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 33. Europe Ocular Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Ocular Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Ocular Drug Delivery Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Ocular Drug Delivery Devices Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Ocular Drug Delivery Devices Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Ocular Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Ocular Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Ocular Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Ocular Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Ocular Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Ocular Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Ocular Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Ocular Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Ocular Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Ocular Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Ocular Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Ocular Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Ocular Drug Delivery Devices Sales (K Units) by Type (2020-2025)

Table 51. Global Ocular Drug Delivery Devices Sales (K Units) by Type (2026-2031)

Table 52. Global Ocular Drug Delivery Devices Sales Market Share by Type (2020-2025)

Table 53. Global Ocular Drug Delivery Devices Sales Market Share by Type (2026-2031)

Table 54. Global Ocular Drug Delivery Devices Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Ocular Drug Delivery Devices Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Ocular Drug Delivery Devices Revenue Market Share by Type (2020-2025)

Table 57. Global Ocular Drug Delivery Devices Revenue Market Share by Type (2026-2031)

Table 58. Global Ocular Drug Delivery Devices Price (US$/Unit) by Type (2020-2025)

Table 59. Global Ocular Drug Delivery Devices Price (US$/Unit) by Type (2026-2031)

Table 60. Global Ocular Drug Delivery Devices Sales (K Units) by Application (2020-2025)

Table 61. Global Ocular Drug Delivery Devices Sales (K Units) by Application (2026-2031)

Table 62. Global Ocular Drug Delivery Devices Sales Market Share by Application (2020-2025)

Table 63. Global Ocular Drug Delivery Devices Sales Market Share by Application (2026-2031)

Table 64. Global Ocular Drug Delivery Devices Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Ocular Drug Delivery Devices Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Ocular Drug Delivery Devices Revenue Market Share by Application (2020-2025)

Table 67. Global Ocular Drug Delivery Devices Revenue Market Share by Application (2026-2031)

Table 68. Global Ocular Drug Delivery Devices Price (US$/Unit) by Application (2020-2025)

Table 69. Global Ocular Drug Delivery Devices Price (US$/Unit) by Application (2026-2031)

Table 70. Alcon Vision Company Information

Table 71. Alcon Vision Description and Business Overview

Table 72. Alcon Vision Ocular Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Alcon Vision Ocular Drug Delivery Devices Product

Table 74. Alcon Vision Recent Developments/Updates

Table 75. Carl Zeiss Company Information

Table 76. Carl Zeiss Description and Business Overview

Table 77. Carl Zeiss Ocular Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Carl Zeiss Ocular Drug Delivery Devices Product

Table 79. Carl Zeiss Recent Developments/Updates

Table 80. Glaukos Corporation Company Information

Table 81. Glaukos Corporation Description and Business Overview

Table 82. Glaukos Corporation Ocular Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Glaukos Corporation Ocular Drug Delivery Devices Product

Table 84. Glaukos Corporation Recent Developments/Updates

Table 85. Ocular Therapeutix Company Information

Table 86. Ocular Therapeutix Description and Business Overview

Table 87. Ocular Therapeutix Ocular Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Ocular Therapeutix Ocular Drug Delivery Devices Product

Table 89. Ocular Therapeutix Recent Developments/Updates

Table 90. Graybug Vision Company Information

Table 91. Graybug Vision Description and Business Overview

Table 92. Graybug Vision Ocular Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Graybug Vision Ocular Drug Delivery Devices Product

Table 94. Graybug Vision Recent Developments/Updates

Table 95. Santen Pharmaceutical Company Information

Table 96. Santen Pharmaceutical Description and Business Overview

Table 97. Santen Pharmaceutical Ocular Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Santen Pharmaceutical Ocular Drug Delivery Devices Product

Table 99. Santen Pharmaceutical Recent Developments/Updates

Table 100. Clearside Biomedical Company Information

Table 101. Clearside Biomedical Description and Business Overview

Table 102. Clearside Biomedical Ocular Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Clearside Biomedical Ocular Drug Delivery Devices Product

Table 104. Clearside Biomedical Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Ocular Drug Delivery Devices Distributors List

Table 108. Ocular Drug Delivery Devices Customers List

Table 109. Ocular Drug Delivery Devices Market Trends

Table 110. Ocular Drug Delivery Devices Market Drivers

Table 111. Ocular Drug Delivery Devices Market Challenges

Table 112. Ocular Drug Delivery Devices Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Ocular Drug Delivery Devices

Figure 2. Global Ocular Drug Delivery Devices Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ocular Drug Delivery Devices Market Share by Type: 2024 & 2031

Figure 4. Ocular Implant Product Picture

Figure 5. Microneedle Product Picture

Figure 6. Ocular Inserts Product Picture

Figure 7. Punctal Plugs Product Picture

Figure 8. Viscosurgical Devices Product Picture

Figure 9. Others Product Picture

Figure 10. Global Ocular Drug Delivery Devices Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Ocular Drug Delivery Devices Market Share by Application: 2024 & 2031

Figure 12. Hospitals

Figure 13. Eye Clinics

Figure 14. Homecare Setting

Figure 15. Others

Figure 16. Global Ocular Drug Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Ocular Drug Delivery Devices Market Size (2020-2031) & (US$ Million)

Figure 18. Global Ocular Drug Delivery Devices Sales (2020-2031) & (K Units)

Figure 19. Global Ocular Drug Delivery Devices Average Price (US$/Unit) & (2020-2031)

Figure 20. Ocular Drug Delivery Devices Report Years Considered

Figure 21. Ocular Drug Delivery Devices Sales Share by Manufacturers in 2024

Figure 22. Global Ocular Drug Delivery Devices Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Ocular Drug Delivery Devices Players: Market Share by Revenue in Ocular Drug Delivery Devices in 2024

Figure 24. Ocular Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Ocular Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Ocular Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 27. North America Ocular Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 28. U.S. Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Ocular Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 31. Europe Ocular Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 32. Germany Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Ocular Drug Delivery Devices Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Ocular Drug Delivery Devices Revenue Market Share by Region (2020-2031)

Figure 39. China Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Taiwan Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Indonesia Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Thailand Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Malaysia Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Philippines Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Latin America Ocular Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 50. Latin America Ocular Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 51. Mexico Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Brazil Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Argentina Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Middle East and Africa Ocular Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Ocular Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 56. Turkey Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. U.A.E Ocular Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Global Sales Market Share of Ocular Drug Delivery Devices by Type (2020-2031)

Figure 60. Global Revenue Market Share of Ocular Drug Delivery Devices by Type (2020-2031)

Figure 61. Global Ocular Drug Delivery Devices Price (US$/Unit) by Type (2020-2031)

Figure 62. Global Sales Market Share of Ocular Drug Delivery Devices by Application (2020-2031)

Figure 63. Global Revenue Market Share of Ocular Drug Delivery Devices by Application (2020-2031)

Figure 64. Global Ocular Drug Delivery Devices Price (US$/Unit) by Application (2020-2031)

Figure 65. Ocular Drug Delivery Devices Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions